Bromelain
•Last Updated: January 10 2022
Bromelain is an enzyme extracted from pineapples. It can reduce heart burn and act as a nasal decongestant.
Bromelain is most often used for
Last Updated: January 10 2022
Bromelain, also called ‘pineapple extract,’ is a combination of several compounds, including a large amount of a special protein-digesting enzyme. This enzyme is able to be digested and thus affect the blood and body, rather than just the stomach and intestines.
When Bromelain is in the stomach, it will help the body break down and digest protein. Supplementation of bromelain can also reduce nasal inflammation, meaning it acts as a decongestant.
If taken between meals, bromelain can benefit the immune system and protect the body from cancer. Bromelain’s effects on fat cells are also under investigation, with promising preliminary evidence.
Bromelain’s anti-inflammatory properties are responsible for several of its effects, including its ability to decongest the nasal cavity. Further research is needed to determine the mechanism through which bromelain survives the digestive system.
There are many anecdotes that say bromelain supplementation will cause semen to taste like pineapple, but no studies have tested this claim.
Note that Bromelain is also known as:
- Pineapple extract
The standard dose for bromelain depends on the goal of supplementation. If the goal is to aid digestion, the standard dose is between 200 – 2,000mg, taken with a meal.
If the goal of supplementation is not digestion related, does range from 200 - 800mg.
Bromelain is typically taken between meals to avoid potential degradation in the stomach. The large range for the standard dose is due to the variations in the enzymatic potential of bromelain, which is standardized by milk clotting units (MCU), or gelatin dissolving units (GDU).
3.^Harrach T, Eckert K, Schulze-Forster K, Nuck R, Grunow D, Maurer HRIsolation and partial characterization of basic proteinases from stem bromelainJ Protein Chem.(1995 Jan)
4.^Purification and characterization of multiple forms of the pineapple-stem-derived cysteine proteinases ananain and comosain.()
5.^Irene D, Chen BJ, Lo SH, Liu TH, Tzen JT, Chyan CLResonance assignments and secondary structure of a phytocystatin from Ananas comosusBiomol NMR Assign.(2012 Apr)
6.^Yoshioka S, Izutsu K, Aso Y, Takeda YInactivation kinetics of enzyme pharmaceuticals in aqueous solutionPharm Res.(1991 Apr)
7.^Ketnawa S, Chaiwut P, Rawdkuen SExtraction of bromelain from pineapple peelsFood Sci Technol Int.(2011 Aug)
8.^Castell JV, Friedrich G, Kuhn CS, Poppe GEIntestinal absorption of undegraded proteins in men: presence of bromelain in plasma after oral intakeAm J Physiol.(1997 Jul)
10.^White RR, Crawley FE, Vellini M, Rovati LABioavailability of 125I bromelain after oral administration to ratsBiopharm Drug Dispos.(1988 Jul-Aug)
11.^Dave S, Dkhar HK, Singh MP, Gupta G, Chandra V, Mahajan S, Gupta PHexafluoroisopropanol-induced helix-sheet transition of stem bromelain: correlation to functionInt J Biochem Cell Biol.(2010 Jun)
12.^Hale LP, Haynes BFBromelain treatment of human T cells removes CD44, CD45RA, E2/MIC2, CD6, CD7, CD8, and Leu 8/LAM1 surface molecules and markedly enhances CD2-mediated T cell activationJ Immunol.(1992 Dec 15)
14.^Pellicano R, Strona S, Simondi D, Reggiani S, Pallavicino F, Sguazzini C, Bonagura AG, Rizzetto M, Astegiano MBenefit of dietary integrators for treating functional dyspepsia: a prospective pilot studyMinerva Gastroenterol Dietol.(2009 Sep)
15.^Borrelli F, Capasso R, Severino B, Fiorino F, Aviello G, De Rosa G, Mazzella M, Romano B, Capasso F, Fasolino I, Izzo AAInhibitory effects of bromelain, a cysteine protease derived from pineapple stem (Ananas comosus), on intestinal motility in miceNeurogastroenterol Motil.(2011 Aug)
16.^Hale LP, Greer PK, Trinh CT, Gottfried MRTreatment with oral bromelain decreases colonic inflammation in the IL-10-deficient murine model of inflammatory bowel diseaseClin Immunol.(2005 Aug)
17.^CD44 antibody against In(Lu)-related p80, lymphocyte-homing receptor molecule inhibits the binding of human erythrocytes to T cells.()
18.^Scheffel JW, Kim YBCharacterization of autologous erythrocyte rosette-forming cells in Minnesota miniature swineCell Immunol.(1981 Jan 1)
19.^Mahajan S, Chandra V, Dave S, Nanduri R, Gupta PStem Bromelain-Induced Macrophage Apoptosis and Activation Curtail Mycobacterium tuberculosis PersistenceJ Infect Dis.(2012 Jun 11)
20.^Hale LP, Greer PK, Sempowski GDBromelain treatment alters leukocyte expression of cell surface molecules involved in cellular adhesion and activationClin Immunol.(2002 Aug)
21.^Fitzhugh DJ, Shan S, Dewhirst MW, Hale LPBromelain treatment decreases neutrophil migration to sites of inflammationClin Immunol.(2008 Jul)
22.^Mynott TL, Ladhams A, Scarmato P, Engwerda CRBromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cellsJ Immunol.(1999 Sep 1)
23.^Kalra N, Bhui K, Roy P, Srivastava S, George J, Prasad S, Shukla YRegulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skinToxicol Appl Pharmacol.(2008 Jan 1)
24.^Bhui K, Prasad S, George J, Shukla YBromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathwayCancer Lett.(2009 Sep 18)
25.^Majima M, Nishiyama K, Iguchi Y, Yao K, Ogino M, Ohno T, Sunahara N, Katoh K, Tatemichi N, Takei Y, Katori MDetermination of bradykinin-(1-5) in inflammatory exudate by a new ELISA as a reliable indicator of bradykinin generationInflamm Res.(1996 Aug)
26.^Ogino M, Majima M, Kawamura M, Hatanaka K, Saito M, Harada Y, Katori MIncreased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: roles of complement, bradykinin, and inducible cyclooxygenase-2Inflamm Res.(1996 Jul)
27.^Wittenborg A, Bock PR, Hanisch J, Saller R, Schneider BComparative epidemiological study in patients with rheumatic diseases illustrated in a example of a treatment with non-steroidal anti- inflammatory drugs versus an oral enzyme combination preparationArzneimittelforschung.(2000 Aug)
28.^Masson MBromelain in blunt injuries of the locomotor system. A study of observed applications in general practiceFortschr Med.(1995 Jul 10)
29.^Akhtar NM, Naseer R, Farooqi AZ, Aziz W, Nazir MOral enzyme combination versus diclofenac in the treatment of osteoarthritis of the knee--a double-blind prospective randomized studyClin Rheumatol.(2004 Oct)
30.^Inoue K, Motonaga A, Dainaka J, Nishimura T, Hashii H, Yamate K, Ueda F, Kimura KEffect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formationProstaglandins Leukot Essent Fatty Acids.(1994 Dec)
31.^Buford TW, Cooke MB, Redd LL, Hudson GM, Shelmadine BD, Willoughby DSProtease supplementation improves muscle function after eccentric exerciseMed Sci Sports Exerc.(2009 Oct)
32.^Miller PC, Bailey SP, Barnes ME, Derr SJ, Hall EEThe effects of protease supplementation on skeletal muscle function and DOMS following downhill runningJ Sports Sci.(2004 Apr)
33.^Neumayer C, Fügl A, Nanobashvili J, Blumer R, Punz A, Gruber H, Polterauer P, Huk ICombined enzymatic and antioxidative treatment reduces ischemia-reperfusion injury in rabbit skeletal muscleJ Surg Res.(2006 Jun 15)
34.^Roep BO, van den Engel NK, van Halteren AG, Duinkerken G, Martin SModulation of autoimmunity to beta-cell antigens by proteasesDiabetologia.(2002 May)
35.^Kempf K, Manzo G, Hanifi-Moghaddam P, Kappler S, Seissler J, Jaeger C, Boehm B, Roden M, Kolb H, Martin S, Schloot NC; PRODIAB Study GroupEffect of combined oral proteases and flavonoid treatment in subjects at risk of Type 1 diabetesDiabet Med.(2009 Dec)
36.^Metzig C, Grabowska E, Eckert K, Rehse K, Maurer HRBromelain proteases reduce human platelet aggregation in vitro, adhesion to bovine endothelial cells and thrombus formation in rat vessels in vivoIn Vivo.(1999 Jan-Feb)
37.^Heinicke RM, van der Wal L, Yokoyama MEffect of bromelain (Ananase) on human platelet aggregationExperientia.(1972 Jul 15)
38.^Felton GEFibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patientsMed Hypotheses.(1980 Nov)
39.^Ley CM, Tsiami A, Ni Q, Robinson NA review of the use of bromelain in cardiovascular diseasesZhong Xi Yi Jie He Xue Bao.(2011 Jul)
40.^Juhasz B, Thirunavukkarasu M, Pant R, Zhan L, Penumathsa SV, Secor ER Jr, Srivastava S, Raychaudhuri U, Menon VP, Otani H, Thrall RS, Maulik NBromelain induces cardioprotection against ischemia-reperfusion injury through Akt/FOXO pathway in rat myocardiumAm J Physiol Heart Circ Physiol.(2008 Mar)
41.^Gaciong Z, Paczek L, Bojakowski K, Socha K, Wisniewski M, Heidland ABeneficial effect of proteases on allograft arteriosclerosis in a rat aortic modelNephrol Dial Transplant.(1996 Jun)
42.^Seligman BOral bromelains as adjuncts in the treatment of acute thrombophlebitisAngiology.(1969 Jan)
43.^Gutfreund AE, Taussig SJ, Morris AKEffect of oral bromelain on blood pressure and heart rate of hypertensive patientsHawaii Med J.(1978 May)
44.^Seneviratne AN, Sivagurunathan B, Monaco CToll-like receptors and macrophage activation in atherosclerosisClin Chim Acta.(2012 Jan 18)
45.^Lauer D, Reichenbach A, Birkenmeier GAlpha 2-macroglobulin-mediated degradation of amyloid beta 1--42: a mechanism to enhance amyloid beta catabolismExp Neurol.(2001 Feb)
46.^Baumhackl U, Kappos L, Radue EW, Freitag P, Guseo A, Daumer M, Mertin JA randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosisMult Scler.(2005 Apr)
47.^Dave S, Kaur NJ, Nanduri R, Dkhar HK, Kumar A, Gupta PInhibition of adipogenesis and induction of apoptosis and lipolysis by stem bromelain in 3T3-L1 adipocytesPLoS One.(2012)
48.^Seltzer APAdjunctive use of bromelains in sinusitis: a controlled studyEye Ear Nose Throat Mon.(1967 Oct)
49.^Ryan REA double-blind clinical evaluation of bromelains in the treatment of acute sinusitisHeadache.(1967 Apr)
50.^Taub SJThe use of bromelains in sinusitis: a double-blind clinical evaluationEye Ear Nose Throat Mon.(1967 Mar)
52.^Braun JM, Schneider B, Beuth HJTherapeutic use, efficiency and safety of the proteolytic pineapple enzyme Bromelain-POS in children with acute sinusitis in GermanyIn Vivo.(2005 Mar-Apr)
53.^NEUBAUER RAA plant protease for potentiation of and possible replacement of antibioticsExp Med Surg.(1961)
54.^Grabovac V, Bernkop-Schnürch AImprovement of the intestinal membrane permeability of low molecular weight heparin by complexation with stem bromelainInt J Pharm.(2006 Dec 1)
55.^Guggi D, Bernkop-Schnürch AImproved paracellular uptake by the combination of different types of permeation enhancersInt J Pharm.(2005 Jan 6)
56.^Renzini G, Varengo MAbsorption of tetracycline in presence of bromelain after oral administrationArzneimittelforschung.(1972 Feb)
57.^Bradbrook ID, Morrison PJ, Rogers HJThe effect of bromelain on the absorption of orally administered tetracyclineBr J Clin Pharmacol.(1978 Dec)
58.^Mialovyts'ka OAEffect of phlogenzym in long-term treatment of patients with multiple sclerosisLik Sprava.(2003 Apr-Jun)
59.^Kerkhoffs GM, Struijs PA, de Wit C, Rahlfs VW, Zwipp H, van Dijk CNA double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymesBr J Sports Med.(2004 Aug)
60.^Shahid SK, Turakhia NH, Kundra M, Shanbag P, Daftary GV, Schiess WEfficacy and safety of phlogenzym--a protease formulation, in sepsis in childrenJ Assoc Physicians India.(2002 Apr)
61.^Szczurko O, Cooley K, Mills EJ, Zhou Q, Perri D, Seely DNaturopathic treatment of rotator cuff tendinitis among Canadian postal workers: a randomized controlled trialArthritis Rheum.(2009 Aug 15)
63.^Montero-Calderón M, Rojas-Graü MA, Martín-Belloso OAroma profile and volatiles odor activity along gold cultivar pineapple fleshJ Food Sci.(2010 Nov-Dec)
64.^MOSS JN, FRAZIER CV, MARTIN GJBROMELAINS. THE PHARMACOLOGY OF THE ENZYMESArch Int Pharmacodyn Ther.(1963 Sep 1)
Primary Use
Gut Health